bromocriptine has been researched along with metyrapone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pratim Roy, P; Roy, K | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gregorová, I; Marek, J; Matys, Z | 1 |
| Hashimoto, K; Hosoki, H; Ofuji, M; Takahara, J; Yunoki, M | 1 |
| Kennedy, AL; Montgomery, DA; Sheridan, B | 1 |
| Kato, Y | 1 |
| Fujita, T; Hirata, Y; Nakashima, H; Tomita, M; Uchihashi, M | 1 |
| Besser, GM; Howlett, TA; Rees, LH | 1 |
| Antunes, RC; de Pinho, MO; Francalanci, CC; Franco, S; Lima, MB | 1 |
| Bergstrand, CG; Nilsson, KO | 1 |
| Badawy, SZ; Marshall, LD; Notman, DD; Omar, MM; Springer, JM; Streeten, DH; Sunderlin, FS | 1 |
| Bricaire, H; Luton, JP | 1 |
| Crapo, L; Miller, JW | 1 |
| Miura, K | 1 |
6 review(s) available for bromocriptine and metyrapone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug therapy of pituitary tumors].
Topics: Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Male; Metyrapone; Octreotide; Pituitary Neoplasms; Prolactinoma | 1991 |
Cushing's syndrome.
Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Alcoholism; Bromocriptine; Circadian Rhythm; Corticotropin-Releasing Hormone; Cushing Syndrome; Cyproheptadine; Depression; Dexamethasone; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Insulin; Male; Metyrapone; Mitotane; Pituitary Gland; Potassium; Prognosis; Prolactin; Thyrotropin-Releasing Hormone; Time Factors; Tomography, X-Ray Computed | 1985 |
Treatment of Cushing's disease in children.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Child; Cushing Syndrome; Cyproheptadine; Dihydrotestosterone; Female; Humans; Metyrapone; Mitotane; Pituitary Gland; Valproic Acid | 1982 |
The medical treatment of Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Aminoglutethimide; Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dogs; Horses; Humans; Ketoconazole; Metyrapone; Mifepristone; Mitotane; Octreotide; Palliative Care; Pituitary Gland; Radiography; Valproic Acid | 1993 |
[Non-invasive therapy of Cushing's syndrome].
Topics: Aminoglutethimide; Betamethasone; Bromocriptine; Clinical Trials as Topic; Cushing Syndrome; Cyproheptadine; Follow-Up Studies; Humans; Metyrapone | 1994 |
1 trial(s) available for bromocriptine and metyrapone
| Article | Year |
|---|---|
ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Bromocriptine; Clinical Trials as Topic; Cushing Syndrome; Drug Evaluation; Female; Humans; Hydrocortisone; Male; Metyrapone; Time Factors | 1978 |
8 other study(ies) available for bromocriptine and metyrapone
| Article | Year |
|---|---|
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cyproheptadine in Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Function Tests; Adult; Bromocriptine; Cushing Syndrome; Cyproheptadine; Drug Evaluation; Female; Humans; Male; Metyrapone; Stimulation, Chemical | 1977 |
[Effects of various drugs on human serum ACTH secretion].
Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Bromocriptine; Dexamethasone; Humans; Hydrocortisone; Lypressin; Metyrapone; Pituitary Diseases; Thyrotropin-Releasing Hormone | 1976 |
Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Animals; beta-Endorphin; Bromocriptine; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethasone; Dopamine; Endorphins; Humans; Male; Metyrapone; Pituitary Neoplasms; Receptors, Dopamine; Sheep | 1985 |
Cushing's disease: clinical and laboratory response to bromocriptine therapy.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Dexamethasone; Female; Humans; Hydrocortisone; Male; Metyrapone | 1984 |
Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hypothalamo-Hypophyseal System; Infertility, Female; Metyrapone; Pituitary Hormones, Anterior; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone | 1982 |
[Cushing's syndrome. Medical treatment of adrenal hypercorticism].
Topics: Adrenal Gland Neoplasms; Aminoglutethimide; Androstanols; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dihydrotestosterone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Metyrapone; Mitotane; Nitriles | 1980 |